产前诊断前置血管妊娠的围产期结局:系统综述与Meta分析
该系统综述与Meta分析纳入21项研究、683例产前诊断前置血管的妊娠,汇总围产期存活率为98.6%(95%CI 97.6-99.3%)。基于7项同时包含产前诊断与未诊断病例的研究,未产前诊断者围产期死亡风险约为产前诊断者的25倍(OR 25.39,95%CI 7.93-81.31,P<0.0001),缺氧性疾病风险约为50倍(OR 50.09,95%CI 17.33-144.79)。作者认为需进一步研究将前置血管产前筛查纳入常规临床实践的策略。
要点
- 产前诊断前置血管者汇总围产期存活率98.6%(95%CI 97.6-99.3%)。
- 未产前诊断者围产期死亡风险约为产前诊断者的25倍(OR 25.39)。
- 未产前诊断者缺氧性疾病风险约为产前诊断者的50倍(OR 50.09)。
关键影像表现/征象
- 产前诊断前置血管的683例妊娠中,死胎3例(1.01%,95%CI 0.40-1.87%)、新生儿死亡5例(1.19%,95%CI 0.52-2.12%),存活新生儿675例。
- 7项研究汇总,无产前诊断者围产期存活61/118(72.1%,95%CI 50.6-89.4%),产前诊断者224/226(98.6%,95%CI 96.7-99.7%)。
- 无产前诊断者缺氧性疾病36/61,产前诊断者5/224(OR 50.09,95%CI 17.33-144.79)。
诊断标准与关键数值
- 产前诊断前置血管者汇总围产期存活率98.6%(95%CI 97.6-99.3%)。
- 未产前诊断者围产期死亡风险为产前诊断者的25.39倍(OR 25.39,95%CI 7.93-81.31,P<0.0001)。
- 未产前诊断者缺氧性疾病风险为产前诊断者的50.09倍(OR 50.09,95%CI 17.33-144.79)。
- 无产前诊断者完整围产期存活率28.1%(95%CI 14.1-44.7%),产前诊断者96.7%(95%CI 93.6-98.8%);率差73.4%(95%CI 53.9-92.7%),Z=-7.4066,P<0.001。
临床应用与阅片要点
- 作者结论认为产前诊断前置血管与较高的围产期存活率相关,未产前诊断显著增加围产期死亡和缺氧性疾病风险。
- 作者提出需进一步研究将前置血管产前筛查纳入常规临床实践的策略。
局限性
- 作者指出需进一步开展研究,探讨将前置血管产前筛查纳入常规临床实践的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To derive accurate estimates of perinatal survival in pregnancies with and without a prenatal diagnosis of vasa previa based on a systematic review of the literature and meta-analysis.
METHODS: A search of MEDLINE, EMBASE and The Cochrane Library was performed to review relevant citations reporting on the perinatal outcomes of pregnancies with vasa previa. We included prospective and retrospective cohort and population studies that provided data on pregnancies with a prenatal diagnosis of vasa previa or cases diagnosed at birth or following postnatal placental examination. Meta-analysis using a random-effects model was performed to derive weighted pooled estimates of perinatal survival (excluding stillbirths and neonatal deaths) and intact perinatal survival (additionally excluding hypoxic morbidity). Incidence rate difference (IRD) meta-analysis was used to estimate the significance of differences in pooled proportions between cases of vasa previa with and those without a prenatal diagnosis. Heterogeneity between studies was estimated using Cochran's Q and the I2 statistic.
RESULTS: We included 21 studies reporting on the perinatal outcomes of 683 pregnancies with a prenatal diagnosis of vasa previa. There were three stillbirths (1.01% (95% CI, 0.40-1.87%)), five neonatal deaths (1.19% (95% CI, 0.52-2.12%)) and 675 surviving neonates, resulting in a pooled estimate for perinatal survival of 98.6% (95% CI, 97.6-99.3%). Based on seven studies that included cases of vasa previa with and without a prenatal diagnosis, the pooled perinatal survival in pregnancies without a prenatal diagnosis (61/118) was 72.1% (95% CI, 50.6-89.4%) vs 98.6% (95% CI, 96.7-99.7%) in cases with a prenatal diagnosis (224/226). Therefore, the risk of perinatal death was 25-fold higher when a diagnosis of vasa previa was not made antenatally, compared with when it was (odds ratio (OR), 25.39 (95% CI, 7.93-81.31); P < 0.0001). Similarly, the risk of hypoxic morbidity was increased 50-fold in cases with vasa previa without a prenatal diagnosis compared with those with a prenatal diagnosis (36/61 vs 5/224; OR, 50.09 (95% CI, 17.33-144.79)). The intact perinatal survival rate in cases of vasa previa without a prenatal diagnosis was significantly lower than in those with a prenatal diagnosis (28.1% (95% CI, 14.1-44.7%) vs 96.7% (95% CI, 93.6-98.8%)) (IRD, 73.4% (95% CI, 53.9-92.7%); Z = -7.4066, P < 0.001).
CONCLUSIONS: Prenatal diagnosis of vasa previa is associated with a high rate of perinatal survival, whereas lack of an antenatal diagnosis significantly increases the risk of perinatal death and hypoxic morbidity. Further research should be undertaken to investigate strategies for incorporating prenatal screening for vasa previa into routine clinical practice. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Zhang W, Geris S, Al-Emara N, et al. Perinatal outcome of pregnancies with prenatal diagnosis of vasa previa: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 32735754. doi:10.1002/uog.22166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。